At the request of a group of Washington, D.C. physicians, the American Medical Association's House of Delegates considered, and rejected, a resolution that would revise the kinds of gifts physicians could accept from the pharmaceutical industry. The D.C. doctors stated that the current guidelines are "cumbersome, onerous, and inconsistent, in that it undervalues physicians' time as professionals."
The physicians want AMA delegates to create a "separate parallel policy" that would allow them to accept gifts "under more realistic guidelines," reported the Chicago Tribune (6/10/04). Current AMA policy allows physicians to accept money for educational or research purposes from the pharmaceutical industry, as long as it comes through another organization or foundation.
The House of Delegates rejected the resolution, according to a preliminary report of its actions. It noted that creating a parallel policy would be confusing and that watering down current AMA guidelines could increase the risk of liability for physicians.
Balancing VTE and bleeding risks in gynecologic cancer surgeries
December 6th 2024A comprehensive analysis shows the benefits of thromboprophylaxis often outweigh the bleeding risks during gynecologic cancer procedures, though patient-specific risk factors are crucial for decision-making.
Read More
Expert consensus sheds light on diagnosis and management of vasa previa
December 5th 2024A recent review established guidelines for prenatal diagnosis and care of vasa previa, outlining its definition, screening and diagnosis, management, and timing of delivery in asymptomatic patients.
Read More